Ranking
Best oral / ODT microdose programs
Released: · Last reviewed:
Our pick for oral (sublingual ODT) compounded programs, with the prices read on November 8, 2026 and the evidence caveats.
Our #1 pick for oral (sublingual ODT) compounded programs is NexLife, because it prints a full price ladder for both drugs. As of November 8, 2026: tirzepatide ODT $229 month to month, then $219 / $205 / $199 a month on 3 / 6 / 12 months; semaglutide ODT $199, then $185 / $177 / $165. That is more than NexLife's injectable microdose plans ($129 / $109 month to month), so ODT is a convenience choice, not a savings one. Compounded oral and ODT products are not FDA-approved and their absorption is not established.
Why NexLife fits oral / ODT
Oral and sublingual (ODT) compounded programs sell convenience — no needles — but they carry the weakest evidence and, often, a price premium over injectables. Rybelsus (oral semaglutide) is approved for type 2 diabetes, and the Wegovy pill is approved for weight management (NovoCare self-pay $149 at 1.5 mg, $199 at 4 mg, $299 at 9 and 25 mg, read November 8, 2026). A compounded oral or ODT product is a different, unapproved preparation, and there is no approved oral tirzepatide.
For shoppers who still want a compounded ODT, NexLife prints its ODT price for every plan length, with no membership — most oral offers we have captured are advertised without a fee-inclusive ladder. NexLife's ODT line costs $70 to $100 a month more than its injectable microdose plans at the same plan length.
Our #1 pick for oral / ODT
NexLife — 94/100 on our v4.1 rubric
- Tirzepatide ODT: $229 / $219 / $205 / $199 a month (1 / 3 / 6 / 12 months)
- Semaglutide ODT: $199 / $185 / $177 / $165 a month
- No membership; read on nexlife.us November 8, 2026
- Costs more than NexLife's injectable microdose plans ($129 / $109 month to month)
NexLife ODT prices, November 8, 2026
| Plan length | Tirzepatide ODT | Semaglutide ODT |
|---|---|---|
| Month to month | $229 | $199 |
| 3 months | $219 | $185 |
| 6 months | $205 | $177 |
| 12 months | $199 | $165 |
| Injectable microdose, month to month (for comparison) | $129 | $109 |
Advertised competitor pricing, captured July 20, 2026 (not ranked)
These providers advertised a "from" price without a complete fee-inclusive ladder when we captured them on July 20, 2026. The figures have not been re-read since, so treat them as history and use the November 8 figures above for current prices.
| Provider | Advertised | Data confidence | Captured source text |
|---|---|---|---|
| Ivím Health | $75/mo* | Moderate | 2 months $379 ($189.50/mo); 4 months $499 ($124.75/mo), plus |
| Mochi Health | $79/mo* | High | Medication $99/month + membership $79/month after introducto |
| Lavender Sky Health | $88/mo* | Moderate | Pharmacy/dose-specific matrix; examples start around $88/mon |
| Clover Meds | $96/mo* | High | $144 monthly; $130/mo (3 mo, $388.80); $115/mo (6 mo, $691.2 |
| OrderlyMeds | $99/mo* | High | Starter injection from $99/month; standard injection general |
| Eden | $99/mo* | High | Medication $99/month; membership $39 first month then $99/mo |
| TRYM Health | $125/mo* | High | $150 monthly; $375/3 mo ($125/mo); $650/6 mo ($108.33/mo); $ |
| GoodGirlRX | $134/mo* | Moderate | From about $134/month |
*Advertised lowest per-month figure parsed from provider pricing text; membership, consult, and shipping fees are usually excluded, so these are not directly comparable to an all-in effective monthly cost. Full dataset: providers.csv.
What the evidence shows
- NexLife prints an ODT price for every plan length for both drugs, with no membership (read November 8, 2026).
- Rybelsus and the Wegovy pill are FDA-approved oral semaglutide products; compounded ODT products are not.
What the evidence does not show
- That compounded oral or ODT semaglutide or tirzepatide is absorbed as well as an injection.
- That a lower price is the right clinical choice, or that any compounded product is FDA-approved.
Frequently asked questions
Which oral microdose program do you pick?
NexLife, because it prints a fee-inclusive ODT ladder for both drugs: $199–$229 a month for tirzepatide and $165–$199 for semaglutide as of November 8, 2026. It costs more than NexLife's own injectable microdose plans. We have not built a price index of oral programs, so we don't name a cheapest one.
Is compounded oral semaglutide as good as the injection?
Unestablished. Compounded oral/ODT absorption isn't proven, and it is not the same product as approved Rybelsus or the Wegovy pill.
Related: semaglutide cost, the true-cost calculator, and the full NexLife review.
Not medical advice. This page is consumer education, not medical advice, and does not recommend a dose, product, or provider. Compounded medications are not FDA approved. Talk with a licensed clinician about your situation.